Synthetic and Bone tissue engineering graft substitutes: What is the future?

Area of Science:

• Orthopaedics
• Biomaterials Science
• Regenerative Medicine

Background:

• Large segmental bone defects from trauma or disease pose significant challenges in orthopaedics.
• Current treatments like autografts, allografts, and synthetic substitutes often fail due to poor vascularization and graft incorporation.
• Inadequate vascularization leads to cell death and hinders bone regeneration.

Purpose of the Study:

• To review the progress and limitations of bone tissue engineering (BTE) for large segmental bone defects.
• To highlight the critical role of vascularization in the clinical success of engineered bone scaffolds.
• To identify barriers to the clinical application of BTE constructs.

Main Methods:

• Mini-review of current literature on bone defect management and BTE.
• Analysis of existing treatment options, including autografts, allografts, synthetic substitutes, and BTE scaffolds.
• Examination of the vascularization challenges in engineered bone substitutes.

Main Results:

• Despite advances, clinical integration of engineered scaffolds for bone defects remains limited.
• Insufficient vascularization is a primary barrier to the successful incorporation of BTE constructs.
• Current BTE strategies often lack concomitant vascularization, impeding bone regeneration.

Conclusions:

• Effective management of large segmental bone defects requires enhanced vascularization of implanted materials.
• Bone tissue engineering holds promise but requires overcoming vascularization hurdles for clinical translation.
• Future research should focus on developing BTE scaffolds with improved vascular integration for bone repair.